Rxsight Inc
NASDAQ:RXST

Watchlist Manager
Rxsight Inc Logo
Rxsight Inc
NASDAQ:RXST
Watchlist
Price: 12.67 USD -4.23%
Market Cap: 514.9m USD

Intrinsic Value

RXST's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one RXST stock under the Base Case scenario is 17.61 USD. Compared to the current market price of 12.67 USD, Rxsight Inc is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RXST Intrinsic Value
17.61 USD
Undervaluation 28%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Rxsight Inc

Valuation History Unavailable

Historical valuation for RXST cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare RXST to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RXST?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Rxsight Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rxsight Inc

Current Assets 288.4m
Cash & Short-Term Investments 229.3m
Receivables 31m
Other Current Assets 28.1m
Non-Current Assets 24.6m
PP&E 23.5m
Other Non-Current Assets 1.2m
Efficiency

Free Cash Flow Analysis
Rxsight Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rxsight Inc

Revenue
148.3m USD
Cost of Revenue
-41.7m USD
Gross Profit
106.6m USD
Operating Expenses
-143.4m USD
Operating Income
-36.9m USD
Other Expenses
10.3m USD
Net Income
-26.5m USD
Fundamental Scores

RXST Profitability Score
Profitability Due Diligence

Rxsight Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

30/100
Profitability
Score

Rxsight Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

RXST Solvency Score
Solvency Due Diligence

Rxsight Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Rxsight Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RXST Price Targets Summary
Rxsight Inc

Wall Street analysts forecast RXST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXST is 22.03 USD with a low forecast of 16.16 USD and a high forecast of 29.4 USD.

Lowest
Price Target
16.16 USD
28% Upside
Average
Price Target
22.03 USD
74% Upside
Highest
Price Target
29.4 USD
132% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Rxsight Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RXST is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RXST Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RXST stock?

The intrinsic value of one RXST stock under the Base Case scenario is 17.61 USD.

Is RXST stock undervalued or overvalued?

Compared to the current market price of 12.67 USD, Rxsight Inc is Undervalued by 28%.

Back to Top